Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.44 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.42 |
| ▸ | POLA1 | P09884 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6197724 | 0.85 | LMNA (0.51) | TP53ALDH1A1LMNAEGLN1MEN1 | |
| SCHEMBL6199742 | 0.83 | EGLN1 (0.51) | ALDH1A1LMNAEGLN1CNR2MEN1 | |
| SCHEMBL6200491 | 0.82 | MAPK1 (0.46) | TP53SCN2ASCN10AALDH1A1LMNA | |
| SCHEMBL6198157 | 0.82 | EGLN1 (0.55) | ALDH1A1LMNAEGLN1CNR2MEN1 | |
| SCHEMBL6200373 | 0.82 | CNR2 (0.47) | TP53ALDH1A1LMNAEGLN1RXFP1 | |
| SCHEMBL6200376 | 0.80 | CNR2 (0.49) | TP53ALDH1A1LMNAEGLN1RXFP1 | |
| SCHEMBL6199161 | 0.79 | EGLN1 (0.47) | TP53LMNAEGLN1CNR2KMT2A | |
| SCHEMBL6196111 | 0.79 | EGLN1 (0.47) | ALDH1A1LMNAEGLN1CNR2MEN1 | |
| SCHEMBL6199118 | 0.79 | EGLN1 (0.47) | ALDH1A1LMNAEGLN1MEN1KMT2A | |
| SCHEMBL6198892 | 0.79 | NR3C1 (0.48) | ALDH1A1LMNAEGLN1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1042295-B1 | 4-HYDROXYQUINOLINE-3-CARBOXAMIDES AND HYDRAZIDES AS ANTIVIRAL AGENTS | PHARMACIA & UPJOHN CO LLC (US) | 2005-09-07 | — | — | EP | disclosed |
| EP-1042295-A1 | 4-HYDROXYQUINOLINE-3-CARBOXAMIDES AND HYDRAZIDES AS ANTIVIRAL AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 2000-10-11 | — | — | EP | disclosed |
| US-6093732-A | PREVENT HERPESVIRAL INFECTIONS, PARTICULARLY, HUMAN CYTOMEGALOVIRAL INFECTION | PHARMACIA & UPJOHN COMPANY (US) | 2000-07-25 | — | — | US | disclosed |
| WO-1999032450-A1 | 4-HYDROXYQUINOLINE-3-CARBOXAMIDES AND HYDRAZIDES AS ANTIVIRAL AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 1999-07-01 | — | — | WO | disclosed |